新生儿HSV-1感染后低TLR-3功能患儿发生抗NMDAR脑炎
本文报道一名新生儿播散性疱疹感染患儿,在停用2年阿昔洛韦抑制治疗后发生单纯疱疹病毒脑炎(HSVE),HSVE缓解后迅速出现行为与神经系统恶化,诊断为抗N-甲基-D-天冬氨酸受体脑炎(抗NMDAR脑炎),并发现其Toll样受体3(TLR-3)功能低下。文章结合文献综述探讨HSVE后抗NMDAR脑炎的临床表现、易感因素、预测结局及免疫缺陷的作用,强调新生儿HSV感染者早期免疫缺陷筛查的价值。
要点
- 新生儿HSVE患儿在HSVE缓解后出现行为与神经症状恶化需警惕抗NMDAR脑炎。
- 新生儿HSV感染患儿应评估免疫缺陷,TLR-3功能低下可能与HSVE后抗NMDAR脑炎相关。
- 早期识别免疫缺陷并干预有助于减轻长期神经残疾、改善生活质量。
核心结论
- 新生儿播散性疱疹感染患儿在停用2年阿昔洛韦抑制治疗后发生HSVE,HSVE缓解后迅速出现行为与神经系统恶化并诊断为抗NMDAR脑炎,且发现TLR-3功能低下。
- 新生儿免疫系统与发育中的大脑对早期病毒暴露尤为脆弱,对新生儿HSV感染患者进行早期免疫缺陷筛查具有重要价值。
研究设计与样本
- 本文为病例报告,描述一名新生儿播散性疱疹感染患儿的临床经过。
- 文章同时复习已发表的儿童HSVE后抗NMDAR脑炎病例及相关文献与原始数据。
主要发现
- 患儿在停用2年阿昔洛韦抑制治疗后发生HSVE。
- HSVE缓解后患者迅速恶化,出现情绪爆发、恐惧、不自主运动及局灶性癫痫发作等显著行为与神经改变。
- 患者诊断为抗NMDAR脑炎,后续发现TLR-3功能低下。
临床怎么用
- 对新生儿HSV感染患儿,应认识到早期免疫缺陷筛查的价值。
- HSVE缓解后出现行为与神经系统恶化时,需考虑抗NMDAR脑炎并进行相应评估。
- 理解该患者群体的免疫特征有助于减轻长期神经残疾并改善生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neonatal herpes simplex virus encephalitis (HSVE) often results in long-lasting neuro-disability in affected children. In addition to primary HSVE and HSVE relapses, children with herpes simplex virus are at increased risk of developing anti-N-methyl-d-aspartate receptor encephalitis (NMDARe), an autoimmune encephalitis. In this study, we describe a patient with neonatal disseminated herpes infection, who developed HSVE after discontinuation of 2 years of acyclovir suppressive therapy. After resolution of HSVE, the patient rapidly deteriorated with significant behavioral and neurologic changes including emotional outbursts, fearfulness, involuntary movements, and focal seizures. The patient was diagnosed with anti-NMDARe and was later found to have low toll-like receptor-3 function. In this study, we review published pediatric cases of anti-NMDARe after HSVE as well as previous literature and primary data examining the presentation, predisposing risk factors, predictive outcomes, future directions, and the role of immunodeficiency in HSVE-mediated anti-NMDARe. The neonatal immune system and developing brain are disproportionately vulnerable to early viral exposure; therefore, it is important to recognize the value of early immunodeficiency screening in patients with neonatal herpes simplex virus. By understanding the immune landscape within this patient population, we can mitigate long-term neurologic disability and improve the quality of life of affected children.
引用
- Manglani M, Poley M, Kumar A, et al. Anti-NMDAR Encephalitis After Neonatal HSV-1 Infection in a Child With Low TLR-3 Function. Pediatrics. 2021. PMID: 34385350. doi:10.1542/peds.2020-035824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。